Post-pandemic Era Global Adoptive Cellular Immunotherapy Market Size, Trends and Opportunties 2022

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Adoptive Cellular Immunotherapy Market Status and Forecast (2017-2028)
1.3.2 Global Adoptive Cellular Immunotherapy Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Adoptive Cellular Immunotherapy Supply by Company
2.1 Global Adoptive Cellular Immunotherapy Sales Value by Company
2.2 Adoptive Cellular Immunotherapy Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Adoptive Cellular Immunotherapy Market Status by Type
3.1 Adoptive Cellular Immunotherapy Type Introduction
3.1.1 TIL
3.1.2 LAK
3.1.3 CAR-T
3.1.4 TCR-T
3.1.5 CIK
3.1.6 NK
3.1.7 DC
3.1.8 Other
3.2 Global Adoptive Cellular Immunotherapy Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 China: by Type
3.6 Japan: by Type
3.7 Asia Other: by Type
4 Global and Regional Adoptive Cellular Immunotherapy Market Status by Application
4.1 Adoptive Cellular Immunotherapy Segment by Application
4.1.1 Hospital
4.1.2 Cancer Hospital
4.1.3 Centers for Disease Control and Prevention
4.1.4 Rehabilitation Center
4.1.5 Other
4.2 Global Adoptive Cellular Immunotherapy Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 China: by Application
4.6 Japan: by Application
4.7 Asia Other: by Application
5 Global Adoptive Cellular Immunotherapy Market Status by Region
5.1 Global Adoptive Cellular Immunotherapy Market by Region
5.2 North America Adoptive Cellular Immunotherapy Market Status
5.3 Europe Adoptive Cellular Immunotherapy Market Status
5.4 China Adoptive Cellular Immunotherapy Market Status
5.5 Japan Adoptive Cellular Immunotherapy Market Status
5.6 Asia Other Adoptive Cellular Immunotherapy Market Status
6 Major Downstream Customers Analysis
6.1 Customer One Analysis
6.2 Customer Two Analysis
6.3 Customer Three Analysis
6.4 Customer Four Analysis
7 Global Adoptive Cellular Immunotherapy Market Forecast by Type and by Application
7.1 Global Adoptive Cellular Immunotherapy Sales Value Forecast (2023-2028)
7.2 Global Adoptive Cellular Immunotherapy Forecast by Type
7.3 Global Adoptive Cellular Immunotherapy Forecast by Application
8 Global Adoptive Cellular Immunotherapy Market Forecast by Region/Country
8.1 Global Adoptive Cellular Immunotherapy Market Forecast by Region (2023-2028)
8.2 North America Market Forecast
8.3 Europe Market Forecast
8.4 China Market Forecast
8.5 Japan Market Forecast
8.6 Asia Other Market Forecast
9 Key Participants Company Information
9.1 Takara Bio Inc
9.1.1 Company Information
9.1.2 Adoptive Cellular Immunotherapy Product Introduction
9.1.3 Takara Bio Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.1.4 Contact Information
9.2 Sorrento Therapeutics Inc
9.2.1 Company Information
9.2.2 Adoptive Cellular Immunotherapy Product Introduction
9.2.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.2.4 Contact Information
9.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
9.3.1 Company Information
9.3.2 Adoptive Cellular Immunotherapy Product Introduction
9.3.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.3.4 Contact Information
9.4 Ono Pharmaceutical Co Ltd
9.4.1 Company Information
9.4.2 Adoptive Cellular Immunotherapy Product Introduction
9.4.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.4.4 Contact Information
9.5 Novartis AG
9.5.1 Company Information
9.5.2 Adoptive Cellular Immunotherapy Product Introduction
9.5.3 Novartis AG Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.5.4 Contact Information
9.6 Nkarta Inc
9.6.1 Company Information
9.6.2 Adoptive Cellular Immunotherapy Product Introduction
9.6.3 Nkarta Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.6.4 Contact Information
9.7 NantKwest Inc
9.7.1 Company Information
9.7.2 Adoptive Cellular Immunotherapy Product Introduction
9.7.3 NantKwest Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.7.4 Contact Information
9.8 Nanjing Legend Biotech Co Ltd
9.8.1 Company Information
9.8.2 Adoptive Cellular Immunotherapy Product Introduction
9.8.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.8.4 Contact Information
9.9 Kite Pharma Inc
9.9.1 Company Information
9.9.2 Adoptive Cellular Immunotherapy Product Introduction
9.9.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.9.4 Contact Information
9.10 Juno Therapeutics Inc
9.10.1 Company Information
9.10.2 Adoptive Cellular Immunotherapy Product Introduction
9.10.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales Value, Gross Margin and Global Share (2020-2022)
9.10.4 Contact Information
9.11 HRAIN Biotechnology Co Ltd
9.12 Hebei Senlang Biotechnology Inc Ltd
9.13 Hangzhou Converd Co Ltd
9.14 Guangzhou Anjie Biomedical Technology Co Ltd
9.15 Gilead Sciences Inc
9.16 Fosun Pharmaceutical AG
9.17 Daiichi Sankyo Co Ltd
9.18 Celyad SA
9.19 Celularity Inc
9.20 Cellular Biomedicine Group Inc
9.21 Cell Medica Ltd
9.22 Celgene Corp
9.23 CARsgen Therapeutics Ltd
9.24 Bristol-Myers Squibb Co
9.25 bluebird bio Inc
9.26 Bellicum Pharmaceuticals Inc
9.27 Beijing Immunochina Medical Science & Technology Co Ltd
9.28 Autolus Therapeutics Plc
9.29 Amgen Inc
10 Conclusion
11 Methodology

no record found